Sarepta Therapeutics | Lånekapital

Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 1.02B 956K 2024-03
Amgen USD 60.06B 3.11B 2024-03
Avrobio USD 15.36M 80K 2023-03
Biogen USD 6.29B 498.1M 2024-03
BioMarin Pharmaceutical USD 593.6M 510K 2024-03
Daiichi Sankyo JPY 101.41B 95M 2023-12
Eli Lilly USD 24.56B 6.64B 2024-03
Gilead Sciences USD 21.53B 1.66B 2024-03
Insmed USD 939.08M 243.26M 2024-03
Ionis Pharmaceuticals USD 1.23B 1.43M 2024-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 60.48B 571M 2024-03
PTC Therapeutics USD 284.51M 1.64B 2024-03
Regeneron Pharmaceuticals USD 1.98B 719.6M 2024-03
Roche Holding CHF 24.81B 4.46B 2023-12
Sarepta Therapeutics USD 1.13B 103.1M 2024-03
Ultragenyx Pharmaceutical USD 0 0 2022-06



Sarepta Therapeutics Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.